Skip to main content
Explore URMC


URMC / Department of Surgery / Cardiac Surgery / Procedures Performed / Surgery for Heart Failure

Surgery for Heart Failure

Heart Failure Program

The Division of Cardiac Surgery at the University of Rochester Medical Center offers the only comprehensive Heart Failure Program in Upstate New York. The Heart Failure Program includes a multidisciplinary team of board-certified physicians, surgeons, and healthcare professionals to treat individuals with congestive heart failure.

Congestive heart failure means the heart doesn’t pump as well as it should, causing the patient to retain fluids, often leading to swollen legs and ankles and congestion in the lungs. It’s usually caused by a gradual weakening of the heart brought on by various conditions, such as clogged arteries, high blood pressure, a defect in the muscular walls or valves of the heart or another medical condition.

Treatment Options

Every patient and their set of symptoms is different and requires an individualized treatment plan. That’s why, at the University of Rochester Medical Center’s Heart Failure Program, all of our patients receive a comprehensive medical evaluation to determine the best possible treatment option.

Often, congestive heart failure is managed through medication, but when this is not effective, there are other interventions and surgical treatments available.

Our services include:

  • Electrophysiology/Arrhythmia Interventions
  • Automatic Intracardiac Defibrillators (AICDs)
  • Arrhythmia ablation
  • Biventricular Resynchronization Therapy: Implantation of a pacemaker type of device which attempts to synchronize the heart’s electrical impulses. This helps the left and right sides of the heart to beat in a more balanced way.
  • Ventricular Assist Program
  • Artificial heart pumps
  • Ventricular assist devices: Devices implanted into the chest cavity to assist the heart to circulate blood. These devices include:
    • Thoratec PVAD and IVAD
    • HeartMate II
    • Centrimag

Surgical Treatment of Heart Failure

  • Coronary Revascularization for Ischemic Cardiomyopathy
  • Destination LVAD therapy (for non-transplant eligible patients with end-stage heart failure)
  • Left Ventricular Reduction surgery
  • High risk Valvular surgery